Triple negative breast carcinoma is a prognostic factor in Taiwanese women (Q33470042)

27 July 2017

title

Triple negative breast carcinoma is a prognostic factor in Taiwanese women (English)

1 reference

27 July 2017

1 reference

Che Lin

1

1 reference

27 July 2017

Su-Yu Chien

2

1 reference

27 July 2017

Li-Sheng Chen

3

1 reference

27 July 2017

Shou-Jen Kuo

4

1 reference

27 July 2017

Tsai-Wang Chang

5

1 reference

27 July 2017

Dar-Ren Chen

6

1 reference

27 July 2017

language of work or name

English

0 references

publication date

18 June 2009

1 reference

27 July 2017

1 reference

27 July 2017

volume

9

1 reference

27 July 2017

page(s)

192

1 reference

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer

27 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706258

Breast cancer stratification from analysis of micro-array data of micro-dissected specimens.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706258

Basal-like breast cancer: a critical review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706258

Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706258

Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706258

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706258

Triple-negative breast cancer: clinical features and patterns of recurrence

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706258

TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706258

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706258

Prognostic markers in triple-negative breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706258

Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706258

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706258

Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706258

Progesterone receptor loss correlates with human epidermal growth factor receptor 2 overexpression in estrogen receptor-positive breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706258

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-192

Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-192

The prognostic importance of triple negative breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-192

Dose-dense and/or metronomic schedules of specific chemotherapies consolidate the chemosensitivity of triple-negative breast cancer: a step toward reversing triple-negative paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-192

The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-192

Is triple negative a prognostic factor in breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-192

The challenging estrogen receptor-negative/ progesterone receptor-negative/HER-2-negative patient: a promising candidate for epidermal growth factor receptor-targeted therapy?

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19534825

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19534825

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

HER2 status in hormone receptor positive premenopausal primary breast cancer adds prognostic, but not tamoxifen treatment predictive, information

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19534825

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2407-9-192

1 reference

Dimensions Publication ID

27 July 2017

0 references

1 reference

27 July 2017

1 reference